Skip to main content
. 2014 Nov 20;147(6):1558–1565. doi: 10.1378/chest.14-1543

TABLE 1 ] .

Baseline Characteristics for 122 Subjects Undergoing Lung Transplant for HP or IPF

Baseline Characteristic HP (n = 31) IPF (n = 91) P Value
Age, y 56.9 ± 9.4 59.7 ± 7.7 .19
Male sex 16 (51.6) 66 (72.5) .032a
Race .50
 White, non-Hispanic 24 (77.4) 70 (76.9)
 Hispanic 5 (16.1) 9 (9.9)
 Other 2 (6.5) 12 (2.2)
Exposure
 Avian 8 (25.8) n/a
 Microbial 4 (12.9) n/a
 Unknown 19 (61.3) n/a
Ever smoker 16 (51.6) 52 (57.1) .59
BMI 25.6 ± 4.1 26.1 ± 3.9 .50
Creatinine level 0.83 ± 0.23 0.90 ± 0.26 .20
FEV1 % predicted 42.1 ± 14.1 54.4 ± 16.8 < .001a
FVC % predicted 37.6 ± 12.5 49.9 ± 16.1 < .001a
FEV1/FVC 0.85 0.84 .44
Mean PAP, mm Hg 23.0 ± 8.9 22.8 ± 9.6 .92
Lung allocation score 56.3 ± 14.9 56.5 ± 19.4 .42
Chronic oral steroids before transplant 24 (77.4) 43 (49.4) < .05a
Donor age, y 33.4 ± 14.6 32.7 ± 13.4 .81
Bilateral lung transplant 27 (87.1) 68 (74.7) .15
Ischemic time, h 5.47 ± 0.96 5.50 ± 1.41 .91

Data presented as mean ± SD or No. (%). HP = hypersensitivity pneumonitis; IPF = idiopathic pulmonary fibrosis; PAP = pulmonary artery pressure.

a

Statistically significant at P ≤ .05.